HIV/AIDS Network Coordination (HANC)
The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS clinical trials networks funded by the Division of AIDS (DAIDS) of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and HIV vaccines. They include the AIDS Clinical Trials Group (ACTG), the HIV Prevention Trials Network (HPTN), the HIV Vaccine Trials Network (HVTN), the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network, and the Microbicide Trials Network (MTN).
HANC is based at the Fred Hutchinson Cancer Research Center in Seattle, Washington and has provided leadership and logistical support for cross-network coordination efforts since 2004. HANC’s mission is to support the science and operations of the networks by increasing efficiency and resource-sharing through coordination of critical activities across networks and with other research and advocacy partners. Efforts focus on: scientific leadership; site management and clinical trials logistics; behavioral science; communications; laboratory operations; the Legacy Project; training development and dissemination; harmonization of data management; development and application of consistent standards of performance evaluation; and facilitating effective community engagement in the research process. HANC is accountable in its activities to DAIDS and Network Leadership.
The HIV Prevention Research training module, a collaboration of the Legacy Project, FHI360, HPTN, HVTN, and MTN, provides recent prevention research findings in a curriculum designed to increase scientific literacy of the communities most disproportionately impacted by HIV. The four hour long module addresses the topics:
- What Is HIV Prevention and the HIV Combination Prevention Toolbox?
- What Are HIV Prevention Tools and How Are They Used in HIV Prevention Research?
The eight-hour long version of the module includes the above content with additional components on:
- What is HIV/AIDS?
- What is Clinical Research?
- What is Community Engagement?
The training modules contain slides with presenter notes, an accompanying participant guide with activities, and an assessment to be used before and after the presentation to assess the participants’ knowledge of HIV research. The training has multiple components designed to stand alone for use in a variety of settings. Depending upon the needs of your audience presenters can create a specific training to address any or all of the topics.
Community representatives working with the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH increasingly felt that this type of guidance was essential and in 2009 sought to develop recommendations as a way to address good community practice. These recommendations are intended as a tool to help research staff and community representatives expand and deepen existing partnerships, and forge new ones, with the ultimate goal of facilitating effective community engagement in all aspects of clinical trials research.
The objectives of this workshop are to:
- Demonstrate how science helps people
- Learn about the scientific method
- Describe scientific research
- Explore the human side of science
These objectives will be met through the use of informational materials (the Participant Guide) and numerous small and whole group activities and discussions. This course will be most successful with people who feel comfortable sharing questions and information.
- Participant Slides
- Participant Slides Spanish Translation
- Participant Handouts
- Participant Guide
- Participant Guide Spanish Translation
- Workshop Activities Handouts
- Participant Slides & Instructor Notes
- Instructor's Guide